Atrial Fibrillation Research Database

University of Campania "Luigi Vanvitelli"

Status: Unknown

Conditions: Atrial Fibrillation; Anticoagulants and Bleeding Disorders

Study type: Observational

Funder types: Other

Identifiers

NCT03760874

19062013

Details and patient eligibility

About

All patients with atrial fibrillation who are treated with vitamin-k antagonists (warfarin, phenprocoumon) or non vitamin K oral anticoagulants (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in real world settings will be recorded in this register. Within this register a characterization of patients and therapy (with regard to medication, dose and duration) will be done. On basis of defined clinical relevant end points the long-term efficacy and safety will be evaluated.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18 to 110 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with atrial fibrillation
• Indication for oral anticoagulant treatment

Exclusion criteria

• Missing Informed Consent Form
• Missing Contact Informations for Follow up

Trial design

5,000 participants in 2 patient groups

Non Vitamin K Oral Anticoagulant

Description:

Dabigatran, Rivaroxaban, Apixaban, Edoxaban

Vitamin K Oral Anticoagulant

Description:

Warfarin, Acenocoumarol.